Lawrence D. Kingsley - 06 May 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role: Director
Signature: /s/ Lily J. Lu, Attorney-in-Fact for Lawrence D. Kingsley
Issuer symbol: IDXX
Transactions as of: 06 May 2025
Net transactions value: $0
Form type: 4
Filing time: 08 May 2025, 19:01:17 UTC
Previous filing: 05 May 2025
Next filing: 16 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kingsley Lawrence D	Director	ONE IDEXX DRIVE, WESTBROOK	/s/ Lily J. Lu, Attorney-in-Fact for Lawrence D. Kingsley	08 May 2025	0001301427

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IDXX	Common Stock	Options Exercise	$0	+262	+2.9%	$0.000000	9,145	06 May 2025	Direct
transaction	IDXX	Common Stock	Options Exercise	$0	+84	+0.92%	$0.000000	9,229	06 May 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IDXX	Restricted Stock Unit	Options Exercise	$0	-262	-100%	$0.000000	0	06 May 2025	Common Stock	262		Direct	F1
transaction	IDXX	Restricted Stock Unit	Options Exercise	$0	-84	-100%	$0.000000	0	06 May 2025	Common Stock	84		Direct	F1, F2
transaction	IDXX	Non-Qualified Stock Option (right-to-buy)	Award	$0	+600		$0.000000	600	07 May 2025	Common Stock	600	$486.61	Direct	F3
transaction	IDXX	Non-Qualified Stock Option (right-to-buy)	Award	$0	+192		$0.000000	192	07 May 2025	Common Stock	192	$486.61	Direct	F2, F3
transaction	IDXX	Restricted Stock Unit	Award	$0	+257		$0.000000	257	07 May 2025	Common Stock	257		Direct	F4
transaction	IDXX	Restricted Stock Unit	Award	$0	+82		$0.000000	82	07 May 2025	Common Stock	82		Direct	F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event was earlier.
F2	Additional grant made as Independent Non-Executive Board Chair.
F3	Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event is earlier.
F4	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event earlier.